$EXPE

Dzielak Robert J sold $946K of EXPE

Dzielak Robert J (Chief Legal Officer & Sec'y) sold 3,003 shares of Expedia Group, Inc. (EXPE) at $315.00 ($0.95M total) on 2026-08-11.

Original reporting
SEC EDGAR · Dzielak Robert J
Published Aug 13, 2026, 8:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EXPE
Neutral
medium confidence
Mentioned
$EXPE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EXPENeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but this specific disclosure lacks fundamental company news (no guidance, deal, or regulatory action).

02

Market read

A newly filed insider sale at a specific price provides limited incremental information and is unlikely to drive sustained repricing without corroborating company-specific catalysts.

03

What to watch

The article does not state whether other insiders sold/bought, whether there were option exercises, or whether the sale was part of a broader compensation plan; also, the absence of a 10b5-1 plan does not by itself imply new negative information.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-13 after-hours; sale dated 2026-08-11

Background

The filing is an SEC Form 4 insider transaction for Expedia Group, Inc. by its Chief Legal Officer and Secretary.

Company-level read

Ticker impact

$EXPENeutralMedium confidence
Context

Expedia insider Dzielak Robert J sold 3,003 shares on 2026-08-11 at $315/share, per a newly filed Form 4.

Expected impact

Likely minimal near-term price impact; any effect is sentiment-driven and short-lived.

Evidence & confidence

Form 4 insider sales are common and often non-informational, and the filing provides no accompanying guidance, operational change, or transaction structure beyond the sale details.

Market effects

No clear read-through to the broader travel/hospitality sector from a single insider sale.

None indicated.

None indicated.

Counterpoint

The sale could be driven by diversification, taxes, or pre-existing personal liquidity needs rather than a bearish view on Expedia.

Key entities

  • Expedia Group, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Dzielak Robert J

    Chief Legal Officer and Secretary who sold 3,003 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ABNBMed

Airbnb Slides to $150 as Wall Street Fears AI Will Skip the Middleman

Airbnb (ABNB) fell 8% to $150 despite 17% revenue growth, as investors reacted to Meta's AI agent Muse, which could bypass travel intermediaries. Booking Holdings (BKNG) and Expedia (EXPE) also dropped. Airbnb's unique inventory and direct host-guest relationships may mitigate AI impact. The stock's consensus target is $184.35.

$METAMed

Meta’s Muse Drags Down Stocks That Depend on ‘Consumer Inertia’

Shares of banks, insurers, and travel agencies fell as investors worry about Meta's AI agent, Muse, disrupting industries reliant on consumer inertia. Meta's stock rose 11% on Monday. Affected companies include JPMorgan, Morgan Stanley, Allstate, Charles Schwab, Expedia, and Booking Holdings. Goldman Sachs identifies telecoms, insurance, and utilities as sectors at risk.

$EXPEMed

Morgan Stanley Cuts Expedia (EXPE) to Underweight as Rivals Pull Ahead on Users

Morgan Stanley downgraded Expedia (EXPE) to Underweight with a $235 price target, citing flat user growth compared to rivals like Booking.com and Airbnb. The analyst noted Expedia's higher marketing costs and exposure to AI-driven search tools. Despite this, Expedia's B2B segment grew 21% in Q2, and the company raised its full-year revenue and margin outlook. The stock has fallen since the downgrade.

$EXPEMed

Wall Street Warning Sends Expedia Shares Sliding

Expedia (EXPE) shares fell after Morgan Stanley initiated coverage with an Underweight rating, citing stagnant user growth and competition. The firm set a $235 price target, despite recent earnings and a smaller upgrade from TD Cowen. Expedia's growth outlook and cash generation remain strong, but debt and slowing revenue growth pose risks.

$EXPEMedAI 8/10

Expedia Stock Is Up Almost 6% This Week. Here’s What’s Behind the Move

Expedia Group (EXPE) stock rose nearly 6% this week after reporting strong Q2 results, beating earnings and revenue estimates for the fifth consecutive quarter. The company raised full-year guidance, citing broad-based growth, particularly in U.S. consumer demand and B2B segment. However, Morgan Stanley initiated coverage with an Underweight rating and a $235 price target, citing concerns about inventory and direct traffic. Expedia's CEO highlighted the company's consistent performance, and a va